New treatment for carpal tunnel syndrome in Hispanic women
Biomechanical treatment of carpal tunnel syndrome for Hispanic women
This study is looking at a new non-surgical treatment called carpal arch space augmentation (CASA) to see if it can help Hispanic women with carpal tunnel syndrome feel better and use their hands more easily, comparing it to the usual brace treatment over eight weeks.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-11014617 on NIH RePORTER |
What this research studies
This research investigates a novel non-surgical treatment called carpal arch space augmentation (CASA) for Hispanic women suffering from carpal tunnel syndrome. The study aims to evaluate the effectiveness of CASA in relieving symptoms and improving hand function compared to standard brace treatment. Participants will be randomly assigned to receive either the CASA intervention or the standard-of-care treatment over an 8-week period, with outcomes measured through patient-reported symptoms and functional assessments. The focus on Hispanic women addresses a significant health disparity in this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are Hispanic women diagnosed with carpal tunnel syndrome.
Not a fit: Patients who do not identify as Hispanic or those who do not have carpal tunnel syndrome may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a more effective non-surgical treatment option for carpal tunnel syndrome, potentially reducing the need for surgery.
How similar studies have performed: While there is ongoing research in carpal tunnel syndrome treatments, the CASA approach is relatively novel and specifically targets the needs of Hispanic women.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Li, Zong-Ming — University of Arizona
- Study coordinator: Li, Zong-Ming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.